336 results
Page 8 of 17
6-K
EX-99.1
mh41tg5vrxe6
3 Jun 13
Live Filing
12:00am
6-K
EX-99
f8v1noflhhc c8q4i
30 May 13
TEVA ANNOUNCES FDA ACCEPTANCE OF sNDA FOR A HIGHER CONCENTRATION DOSE OF COPAXONE®GIVEN THREE TIMES A WEEK
12:00am
6-K
EX-99.1
37ddnnlgsnnhhwjsbr
8 May 13
Adasuve® (loxapine) inhalation powder is approved in the U.S. for the acute treatment of agitation associated with schizophrenia and bipolar disorder
12:00am
6-K
EX-32.1
uhcvyttzi9g3a
6 May 13
Live Filing
12:00am
6-K
EX-99.1
45hpfu
2 May 13
Teva Reports First Quarter 2013 Results
12:00am
6-K
j8sw v7dfa1z
2 May 13
Current report (foreign)
12:00am
6-K
EX-99.1
dn0q9s7d fnyw
1 May 13
FDA Approves Over-The-Counter Availability of Plan B One-Step® (levonorgestrel) tablet 1.5 mg for Consumers 15 and Over
12:00am
6-K
EX-99.1
qf0corsh8y22mn7irj
23 Apr 13
Teva and Xenon Announce FDA Orphan Drug Designation for Pain Drug XEN402
12:00am
6-K
EX-99.1
3m5ioxv0
17 Apr 13
Data Reported Comparable Multiple Pregnancy Rates Among Patients Treated with Investigational Milprosa™ and Progesterone Vaginal Gel
12:00am
6-K
EX-99.1
6tc ujdgv
29 Mar 13
Live Filing
12:00am
6-K
EX-99.1
oghfwbv4
21 Mar 13
Live Filing
12:00am
6-K
EX-99.1
bfa7ufjpp8q
20 Mar 13
Live Filing
12:00am
6-K
EX-99.1
9no fxmql
14 Mar 13
Teva to Present New Research on CNS Product Portfolio and Pipeline at 2013 American Academy of Neurology Annual Meeting
12:00am
6-K
EX-99.1
6rzyhfg3t0q8eqi0
6 Mar 13
Live Filing
12:00am
6-K
EX-99.1
ct2v6hp
4 Mar 13
Live Filing
12:00am
6-K
EX-99.1
gppq 9txcy9
22 Feb 13
Additional QNASL® (beclomethasone dipropionate) Nasal Aerosol Data to be Presented at Annual Allergy Meeting
12:00am
6-K
EX-99.1
zpy71a
14 Feb 13
Live Filing
12:00am
6-K
EX-99.1
4gqlmw78qf9slsvap
11 Feb 13
Teva Pharmaceuticals Announces Appointment of Dr. Arie Belldegrun to Board of Directors
12:00am
6-K
EX-99.1
ku9r 3hg7r1ezr8a1vuz
7 Feb 13
Teva Reports Fourth Quarter and Full Year 2012 Results
12:00am